Effect of Flixweed and Fig on Irritable Bowel Syndrome With Predominant Constipation: a Single Blind Randomized Clinical Trial.

Isfahan University of Medical Sciences150 enrolled

Overview

This study evaluates effect of Ficus carica and Descurainia Sophia on irritable bowel syndrome predominant constipation. one-third of patients will receive Ficus carica, another one-third will receive Descurainia Sophia and remained patients only will follow their regular diet for 4 months.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

150

Conditions

Irritable Bowel Syndrome Predominant Constipation

Interventions

Descurainia SophiaOTHER

Ficus caricaOTHER

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients with irritable bowel syndrome predominant constipation Exclusion Criteria: * Subjects with significant cardiovascular, renal, hepatic, pulmonary, endocrine, metabolic, hematologic disorders, * structural abnormalities of the gastrointestinal tract or * diseases ⁄conditions that affected bowel transition, * surgery, * any prokinetic or laxative drug used during the past month, * any medication that may affect gastrointestinal motility, * other therapeutic dietary advice for IBS, * used Fig or Flixweed during the last month, * diarrhea, * pregnancy or * breast-feeding

Locations (1)

Gastrointestinal Research Center

Isfahan, Iran

Outcomes

Primary Outcomes

irritable bowel syndrome constipation predominant symptom

IBS severity score system questionnaires will use for evaluation of IBS-C symptoms at the pre and post-intervention. This tool is validated for use in IBS patients that assess 5 clinically relevant items during past 10-days and including severity of abdominal pain, frequency of abdominal pain, severity of abdominal distention, dissatisfaction with bowel movement and interference of IBS with life in general. Each items was scored with a 100 mm visual analogue scale (VAS).

Time frame: 4 months

Secondary Outcomes

quality of life in IBS-C patients

quality of life in IBS-C patients were assessed at pre-and post-intervention using a self-report Irritable Bowel Syndrome-Quality of Life Measure (IBS-QoL). It contains 34 items with 8 sub-classification including dysphoria, interference with activity, body image, health worry, food avoidance, social reaction, sexual, and relationships. The sum of response to this items by every subject were average and transform to 0-100 scale. The higher score indicated better quality of life among IBS-C patients.

Time frame: 4 months

frequency of defecation and hard stool

frequency of defecation and hard stool was evaluated at baseline and end of every month using the visual analogue scale (VAS)

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.